RONALD WATTS, M.D., F.A.C.E
Specialist in STOCKBRIDGE, Georgia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
RONALD WATTS, M.D., F.A.C.E reported a CMS MIPS final score of 92.2614/100 — above the 83.1 national average — and filed 10,353 Medicare Part D claims in 2023.
- 92.2614/100
- MIPS score · +9 vs avg
- 10K
- Part D claims, 2023
- 52%
- generic prescribing
- $4.6K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
RONALD WATTS, M.D., F.A.C.E's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
92 Top 32% higher than 68% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about RONALD WATTS, M.D., F.A.C.E?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Georgia
How Specialist compares to other specialties among Georgia providers
Specialist share within Georgia
Specialist is one of the more visible NUCC categories in Georgia
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
RONALD WATTS, M.D., F.A.C.E's 2023 MIPS final score plotted against the Specialist national average
- MIPS Final Score
- 92.2614/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Specialist) — 92.2614/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Specialist US NPIs
92.2614/100 MIPS final score — 9.2 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Specialist. Quality dim: 73.8353.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
RONALD WATTS, M.D., F.A.C.E appears in the CMS NPPES registry as a Specialist provider holding M.D., F.A.C.E credentials at 550 EAGLES LANDING PKWY STE 110, STOCKBRIDGE, GA, 30281, with a listed phone of (770) 389-9494. NPI 1942301759 was issued on 09/26/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WATTS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 10,353 prescription claims written by this provider, covering 991 Medicare beneficiaries and totaling roughly $6.8 million in drug spend, split 48% brand-name and 52% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 92.2614/100 for the 2023 performance year (Quality 73.8353), compared with the national average of 83.1.
Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1942301759 |
|---|---|
| Specialty | Specialist |
| Credentials | M.D., F.A.C.E |
| Gender | Male |
| NPI Issued | 09/26/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm RONALD WATTS, M.D., F.A.C.E's current license status, disciplinary history, and board certifications with the Georgia Composite Medical Board in Georgia before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RONALD WATTS, M.D., F.A.C.E. Source: openpaymentsdata.cms.gov.
Total received
$4.6K
Largest payer
Xeris Pharmaceuticals, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
48% brand-name claims vs 52% generic, on 10,353 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 22,008
- Total Day Supply
- 652,743
- Brand vs Generic
- 48% brand / 52% generic
- Brand Drug Cost
- $6.5M
- Generic Drug Cost
- $101K
- Antibiotic Claims
- 41
Patient Demographics
- Average Patient Age
- 69.4 years
- Avg HCC Risk Score
- 1.95
- Gender Split
- 67% female / 33% male
- Age Distribution
- <65: 225, 65-74: 444, 75-84: 285, 85+: 37
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What RONALD WATTS, M.D., F.A.C.E prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
787 claims
- Trulicity
Trulicity
578 claims
- Metformin Hcl
Metformin Hcl
388 claims
- Farxiga
Farxiga
386 claims
- Atorvastatin Calcium
Atorvastatin Calcium
382 claims
- Novolog Flexpen 293
Novolog Flexpen
293 claims
- Ozempic 278
Ozempic
278 claims
- Jardiance 270
Jardiance
270 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 787 |
| Trulicity Dulaglutide | 578 |
| Metformin Hcl | 388 |
| Farxiga Dapagliflozin Propanediol | 386 |
| Atorvastatin Calcium | 382 |
| Novolog Flexpen Insulin Aspart | 293 |
| Ozempic Semaglutide | 278 |
| Jardiance Empagliflozin | 270 |
| Rosuvastatin Calcium | 269 |
| Amlodipine Besylate | 206 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Specialist Overview
How RONALD WATTS, M.D., F.A.C.E fits within the Specialist landscape nationally.
RONALD WATTS, M.D., F.A.C.E's 10,353 claims are above the specialty average of 1,474.
Nearby Specialist Providers in Georgia
Other clinicians with the same primary specialty enrolled in Georgia, drawn from the same CMS NPPES roster as WATTS.
Compare Specialist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Georgia
Frequently Asked Questions
What is RONALD WATTS, M.D., F.A.C.E's specialty? ▼
How much does RONALD WATTS, M.D., F.A.C.E prescribe under Medicare Part D? ▼
What is RONALD WATTS, M.D., F.A.C.E's Medicare quality score? ▼
Where is RONALD WATTS, M.D., F.A.C.E located? ▼
What is RONALD WATTS, M.D., F.A.C.E's NPI number? ▼
Does RONALD WATTS, M.D., F.A.C.E prescribe more brand-name or generic drugs? ▼
How many Specialist providers are there in the US? ▼
What drugs does RONALD WATTS, M.D., F.A.C.E prescribe most often? ▼
Does RONALD WATTS, M.D., F.A.C.E accept Medicare? ▼
How can I verify RONALD WATTS, M.D., F.A.C.E's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology